Author:
Imrichova D.,Messingerova L.,Seres M.,Kavcova H.,Pavlikova L.,Coculova M.,Breier A.,Sulova Z.
Reference55 articles.
1. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance;Barancik;Eur. J. Pharm. Sci.,2001
2. LY294, 002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance;Barancik;Eur. J. Pharm. Sci.,2006
3. P-glycoprotein-implications of metabolism of neoplastic cells and cancer therapy;Breier;Curr. Cancer Drug Targets,2005
4. New insight into p-glycoprotein as a drug target;Breier;Anticancer Agents Med. Chem.,2013
5. Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of L1210 cells using sialic acid binding lectins;Bubencikova;Int. J. Mol. Sci.,2012
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献